Safety and Immunogenicity of the BBIBP-CorV Vaccine in Adolescents Aged 12 to 17 Years in the Thai Population: An Immunobridging Study

Adolescents can develop a severe form of Coronavirus disease 2019 (COVID-19), especially with underlying comorbidities. No study has examined the efficacy or effectiveness of inactivated COVID-19 vaccines in adolescents. This single-center, prospective cohort study was performed to evaluate the safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawinprai, Kriangkrai, Siripongboonsitti, Taweegrit, Porntharukchareon, Thachanun, Vanichsetakul, Preeda, Thonginnetra, Saraiorn, Niemsorn, Krongkwan, Promsena, Pathariya, Tandhansakul, Manunya, Kasemlawan, Naruporn, Ruangkijpaisal, Natthanan, Banomyong, Narin, Phattraprayoon, Nanthida, Ungtrakul, Teerapat, Wittayasak, Kasiruck, Thonwirak, Nawarat, Soonklang, Kamonwan, Sornsamdang, Gaidganok, Mahanonda, Nithi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143729/
https://www.ncbi.nlm.nih.gov/pubmed/35632562
http://dx.doi.org/10.3390/vaccines10050807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143729/
https://www.ncbi.nlm.nih.gov/pubmed/35632562
http://dx.doi.org/10.3390/vaccines10050807

Ejemplares similares